{"first_name":"David","last_name":"M. Spencer","permalink":"david-m-spencer","crunchbase_url":"http://www.crunchbase.com/person/david-m-spencer","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Thu Nov 05 01:47:38 UTC 2009","updated_at":"Sat Mar 26 06:48:58 UTC 2011","overview":"<p>David Spencer, Professor and Vice Chairman of Pathology &amp; Immunology, Baylor College of Medicine, is the original inventor of CID technology. Drs. Spencer and Slawin are co-inventors of DeCIDeâ„¢ and CaspaCIDeâ„¢, the two CID applications that have since entered the clinic. Dr. Spencerâ€™s academic research program remains focused on CID, and he directs Bellicumâ€™s preclinical research activities.\nTo complement the founding management team, we use consultants in the areas of manufacturing, quality, and regulatory affairs, and we use a full service CRO for clinical trials management.</p>","image":null,"degrees":[],"relationships":[{"is_past":false,"title":"CSO","firm":{"name":"Bellicum Pharmaceuticals","permalink":"bellicum-pharmaceuticals","type_of_entity":"company","image":{"available_sizes":[[[150,51],"assets/images/resized/0006/4954/64954v1-max-150x150.png"],[[230,79],"assets/images/resized/0006/4954/64954v1-max-250x250.png"],[[230,79],"assets/images/resized/0006/4954/64954v1-max-450x450.png"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}